Works by Van den Eynde, Benoît J

Results: 20

Production of an antigenic peptide by insulin-degrading enzyme.

Published in:

Nature Immunology, 2010, v. 11, n. 5, p. 449, doi. 10.1038/ni.1862

By:

Parmentier, Nicolas;
Stroobant, Vincent;
Colau, Didier;
de Diesbach, Philippe;
Morel, Sandra;
Chapiro, Jacques;
van Endert, Peter;
Van den Eynde, Benoît J

Publication type:

Article

Editorial: Heme proteins: key players in the regulation of immune responses.

Published in:

Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1263384

By:

Volpi, Claudia;
Van den Eynde, Benoît J.;
Orabona, Ciriana

Publication type:

Article

Tryptophan-degrading enzymes in tumoral immune resistance.

Published in:

Frontiers in Immunology, 2015, v. 6, p. 1, doi. 10.3389/fimmu.2015.00034

By:

van Baren, Nicolas;
Van den Eynde, Benoît J.

Publication type:

Article

Inefficient exogenous loading of a tapasin-dependent peptide onto HLA- B*44:02 can be improved by acid treatment or fixation of target cells.

Published in:

European Journal of Immunology, 2012, v. 42, n. 6, p. 1417, doi. 10.1002/eji.201141954

By:

Stroobant, Vincent;
Demotte, Nathalie;
Luiten, Rosalie M.;
Leonhardt, Ralf M.;
Cresswell, Peter;
Bonehill, Aude;
Michaux, Alexandre;
Ma, Wenbin;
Mulder, Arend;
Van den Eynde, Benoît J.;
van der Bruggen, Pierre;
Vigneron, Nathalie

Publication type:

Article

The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen.

Published in:

International Journal of Cancer, 1997, v. 70, n. 3, p. 349, doi. 10.1002/(SICI)1097-0215(19970127)70:3<349::AID-IJC17>3.0.CO;2-A

By:

Uyttenhove, Catherine;
Godfraind, Catherine;
Lethé, Bernard;
Amar-Costesec, Alain;
Renauld, Jean-Christophe;
Gajewski, Thomas F.;
Duffour, Marie-Thérèse;
Warnier, Guy;
Boon, Thierry;
Van den Eynde, Benoît J.

Publication type:

Article

Renal-cell carcinoma-specific lysis by cytotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes.

Published in:

International Journal of Cancer, 1996, v. 68, n. 2, p. 177, doi. 10.1002/(SICI)1097-0215(19961009)68:2<177::AID-IJC6>3.0.CO;2-V

By:

Brouwenstijn, Nathalie;
Gaugler, Béatrice;
Krüse, K. Margaretha;
van der Spek, Corry W.;
Mulder, Arend;
Osanto, Susanne;
van den Eynde, Benoît J.;
Schrier, Peter I.

Publication type:

Article

Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistance.

Published in:

OncoImmunology, 2015, v. 4, n. 5, p. 0, doi. 10.1080/2162402X.2014.1003012

By:

Vigneron, Nathalie;
van Baren, Nicolas;
Van den Eynde, Benoît J

Publication type:

Article

Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2.

Published in:

International Journal of Cancer, 2004, v. 109, n. 5, p. 698, doi. 10.1002/ijc.20038

By:

Ma, Wenbin;
Germeau, Catherine;
Vigneron, Nathalie;
Maernoudt, Anne-Sophie;
Morel, Sandra;
Boon, Thierry;
Coulie, Pierre G.;
Van den Eynde, Benoît J.

Publication type:

Article

A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes.

Published in:

International Journal of Cancer, 1999, v. 83, n. 6, p. 755, doi. 10.1002/(SICI)1097-0215(19991210)83:6<755::AID-IJC10>3.0.CO;2-S

By:

Morel, Sandra;
Ooms, Annie;
Van Pel, Aline;
Wölfel, Thomas;
Brichard, Vincent G.;
Van der Bruggen, Pierre;
Van den Eynde, Benoît J.;
Degiovanni, Gérard

Publication type:

Article

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.

Published in:

Nature Medicine, 2003, v. 9, n. 10, p. 1269, doi. 10.1038/nm934

By:

Uyttenhove, Catherine;
Pilotte, Luc;
Théte, Ivan;
Stroobant, Vincent;
Colau, Didier;
Parmentier, Nicolas;
Boon, Thierry;
Van den Eynde, Benoît J.

Publication type:

Article

Genotypic and Gene Expression Studies in Congenital Melanocytic Nevi: Insight into Initial Steps of Melanotumorigenesis.

Published in:

Journal of Investigative Dermatology, 2009, v. 129, n. 1, p. 139, doi. 10.1038/jid.2008.203

By:

Dessars, Barbara;
De Raeve, Linda E.;
Morandini, Renato;
Lefort, Anne;
El Housni, Hakim;
Ghanem, Ghanem E.;
Van den Eynde, Benoît J;
Ma, Wenbin;
Roseeuw, Diane;
Vassart, Gilbert;
Libert, Frédérick;
Heimann, Pierre

Publication type:

Article

Proteasome Subtypes and Regulators in the Processing of Antigenic Peptides Presented by Class I Molecules of the Major Histocompatibility Complex.

Published in:

Biomolecules (2218-273X), 2014, v. 4, n. 4, p. 994, doi. 10.3390/biom4040994

By:

Vigneron, Nathalie;
Van den Eynde, Benoît J.

Publication type:

Article

Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.

Published in:

International Immunology, 2003, v. 15, n. 12, p. 1423, doi. 10.1093/intimm/dxg144

By:

Gilles Dadaglio;
Sandra Morel;
Cécile Bauche;
Zhora Moukrim;
François A. Lemonnier;
Benoît J. Van den Eynde;
Daniel Ladant;
Claude Leclerc

Publication type:

Article

A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy.

Published in:

International Journal of Cancer, 2011, v. 129, n. 10, p. 2427, doi. 10.1002/ijc.25911

By:

Ma, Wenbin;
Vigneron, Nathalie;
Chapiro, Jacques;
Stroobant, Vincent;
Germeau, Catherine;
Boon, Thierry;
Coulie, Pierre G.;
Van den Eynde, Benoît J.

Publication type:

Article

Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

Published in:

Nature Reviews Cancer, 2014, v. 14, n. 2, p. 135, doi. 10.1038/nrc3670

By:

Coulie, Pierre G.;
Van den Eynde, Benoît J.;
van der Bruggen, Pierre;
Boon, Thierry

Publication type:

Article

Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

Published in:

2014

By:

Coulie, Pierre G;
Van den Eynde, Benoît J;
van der Bruggen, Pierre;
Boon, Thierry

Publication type:

journal article

Tryptophan-degrading enzymes in tumoral immune resistance.

Published in:

Frontiers in Immunology, 2016, v. 6/7, p. 1, doi. 10.3389/fimmu.2015.00034

By:

van Baren, Nicolas;
Van den Eynde, Benoît J.

Publication type:

Article

Heterogeneity of Synovial Molecular Patterns in Patients with Arthritis.

Published in:

PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0122104

By:

Lauwerys, Bernard R.;
Hernández-Lobato, Daniel;
Gramme, Pierre;
Ducreux, Julie;
Dessy, Adrien;
Focant, Isabelle;
Ambroise, Jérôme;
Bearzatto, Bertrand;
Nzeusseu Toukap, Adrien;
Van den Eynde, Benoît J.;
Elewaut, Dirk;
Gala, Jean-Luc;
Durez, Patrick;
Houssiau, Frédéric A.;
Helleputte, Thibault;
Dupont, Pierre

Publication type:

Article

Differences in the production of spliced antigenic peptides by the standard proteasome and the immunoproteasome.

Published in:

European Journal of Immunology, 2011, v. 41, n. 1, p. 39, doi. 10.1002/eji.201040750

By:

Dalet, Alexandre;
Stroobant, Vincent;
Vigneron, Nathalie;
Van den Eynde, Benoît J.

Publication type:

Article

The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection.

Published in:

European Journal of Immunology, 1998, v. 28, n. 12, p. 4010, doi. 10.1002/(SICI)1521-4141(199812)28:12<4010::AID-IMMU4010>3.0.CO;2-5

By:

Brändle, Daniel;
Bilsborough, Janine;
Rülicke, Thomas;
Uyttenhove, Catherine;
Boon, Thierry;
Van den Eynde, Benoît J.

Publication type:

Article